Brief: Coherus Oncology Q4 Sales USD 12.748 Million Vs. IBES Estimate USD 13.9 Million
09/03/2026 20:15
Mar 09 (Reuters) - Coherus Oncology Q4 adjusted net income USD -40.42 million vs. IBES estimate USD -35.1 million. Q4 operating income USD -45.88 million Q4 net income USD -37.643 million Q4 EPS USD -1.56
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million